International. Secop has developed the technology for an ultra-low temperature cooling system. This system is optimized for the last mile of distribution for new generations of vaccines and offers mobile operation even in high environmental conditions such as in tropical regions.
This solution with an MP2UVULTM compressor leverages Secop's expertise in medical applications, vaccine solar freezers and mobile solutions and combines all these areas of use.
Battery-powered active cooling systems for mRNA-based vaccines offer many advantages compared to existing passive cooling (dry ice) transport boxes. Active systems offer temperature control, do not need large amounts of dry ice, are reusable, do not waste tons of CO2 and prevent vaccine waste.
They are suitable for any distribution point, even in remote areas where CO2 availability cannot be guaranteed or environmental conditions are severe.
Proceeds:
Mobile solution capable of reaching from -70°C to -86°C
Ideal solution for mains voltage. Independent transportation of mRNA-based COVID-19 vaccines
Precise cooling and control of the target temperature
Perfect for transporting vaccines with temperature control and no risk of vaccine waste
Reliable and durable systems with a low total cost of ownership lifecycle
Optimized and proven design for robust transport boxes
Electronically controlled variable speed drive compressor
Easy controller customization ° CCD® (Cool Capacity Drive) via Tool4Cool®
Leave your comment